Consistent safety and tolerability of Valtoco ® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety study.

MLA

Miller, Ian, et al. “Consistent Safety and Tolerability of Valtoco ® (Diazepam Nasal Spray) in Relationship to Usage Frequency in Patients with Seizure Clusters: Interim Results from a Phase 3, Long-Term, Open-Label, Repeat-Dose Safety Study.” Epilepsia Open, vol. 6, no. 3, Sept. 2021, pp. 504–12. EBSCOhost, https://doi.org/10.1002/epi4.12494.

APA

Miller, I., Wheless, J. W., Hogan, R. E., Dlugos, D., Biton, V., Cascino, G. D., Sperling, M. R., Liow, K., Vazquez, B., Segal, E. B., Tarquinio, D., Mauney, W., Desai, J., Rabinowicz, A. L., & Carrazana, E. (2021). Consistent safety and tolerability of Valtoco ® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety study. Epilepsia Open, 6(3), 504–512. https://doi.org/10.1002/epi4.12494

Chicago

Miller, Ian, James W Wheless, Robert E Hogan, Dennis Dlugos, Victor Biton, Gregory D Cascino, Michael R Sperling, et al. 2021. “Consistent Safety and Tolerability of Valtoco ® (Diazepam Nasal Spray) in Relationship to Usage Frequency in Patients with Seizure Clusters: Interim Results from a Phase 3, Long-Term, Open-Label, Repeat-Dose Safety Study.” Epilepsia Open 6 (3): 504–12. doi:10.1002/epi4.12494.